Production of bioengineered outer membrane vesicles as vaccine platform

Outer membrane vesicles (OMVs) are spherical nanoparticles produced by bacteria. OMVs encompass only the outside of the bacterium and are well suited as vaccines. When heterologous antigens are added, the OMV can be utilized as vaccine platform. This project tests the capabilities of such a platform.